chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Joint effusion, Joint fluid drainage, Muscle tightness, Oedema peripheral, Peripheral venous disease
Clinical narrative: On March 11, 2021, 9 weeks after my initial dose of Moderna Covid vaccine (lot #011J20A) and 5 weeks after my second dose thereof, I began to feel tightness in the area of my upper right gastrocnemius muscle and lower popliteal fossa, particularly while running.  Examination of the area was unremarkable.  On March 16, after a 3-hour airplane flight, I noticed 2+ right leg edema with no erythema.  On March 20, a venous duplex study of the right leg revealed venous insufficiency (valvular incompetence), with no evidence of venous thrombosis.  Use of a below-the-knee compression stocking was prescribed.  With use of the stocking, daytime edema was 1+; edema resolved completely, though temporarily, during nighttime recumbency.  In July, 2021, I began to use a compression stocking that extended to the upper thigh.  After 3 weeks, the edema had permanently resolved, and the feeling of tightness had also resolved.  On October 24, 2021, I received a booster dose of Moderna Covid vaccine (lot #012F21A).  On October 27, I noted recurrence of the right upper gastrocnemius tightness, with no erythema.  Use of the thigh-level stocking was resumed for 3 weeks.  The feeling of tightness resolved, and edema did not recur.  On March 21, 2021, a large right olecranon bursa effusion, with no erythema or pain, was noted.  Fluid was removed: no sodium urate crystals were seen, and culture was negative. The effusion resolved permanently after use of an elastic elbow band for 3 weeks.  Allopurinol 200 mg qd was initiated for treatment of chronic hyperuricemia and suspected gout; allopurinol therapy is ongoing.    Relationship of these adverse events to the vaccine is considered possible.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Ultrasound Doppler abnormal
Clinical narrative: On March 11, 2021, 9 weeks after my initial dose of Moderna Covid vaccine (lot #011J20A) and 5 weeks after my second dose thereof, I began to feel tightness in the area of my upper right gastrocnemius muscle and lower popliteal fossa, particularly while running.  Examination of the area was unremarkable.  On March 16, after a 3-hour airplane flight, I noticed 2+ right leg edema with no erythema.  On March 20, a venous duplex study of the right leg revealed venous insufficiency (valvular incompetence), with no evidence of venous thrombosis.  Use of a below-the-knee compression stocking was prescribed.  With use of the stocking, daytime edema was 1+; edema resolved completely, though temporarily, during nighttime recumbency.  In July, 2021, I began to use a compression stocking that extended to the upper thigh.  After 3 weeks, the edema had permanently resolved, and the feeling of tightness had also resolved.  On October 24, 2021, I received a booster dose of Moderna Covid vaccine (lot #012F21A).  On October 27, I noted recurrence of the right upper gastrocnemius tightness, with no erythema.  Use of the thigh-level stocking was resumed for 3 weeks.  The feeling of tightness resolved, and edema did not recur.  On March 21, 2021, a large right olecranon bursa effusion, with no erythema or pain, was noted.  Fluid was removed: no sodium urate crystals were seen, and culture was negative. The effusion resolved permanently after use of an elastic elbow band for 3 weeks.  Allopurinol 200 mg qd was initiated for treatment of chronic hyperuricemia and suspected gout; allopurinol therapy is ongoing.    Relationship of these adverse events to the vaccine is considered possible.
Age: 95.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: COVID-19 infection breakthrough. Fully vaccinated, not boosted.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: General symptom
Clinical narrative: Onset of symptoms 1/18/22
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Malaise, SARS-CoV-2 test positive
Clinical narrative: Tested positive for Covid 19 on 1/22 after not feeling well for two days.  Did not feel well for 5 days.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Amylase, Chromaturia, Culture urine, Full blood count, Laboratory test
Clinical narrative: Pt reported that she developed dark urine 2 days post vaccine. Pt states that the same thing happened when she received second dose of CV-19 vaccine.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Lipase, Metabolic function test, Urine analysis
Clinical narrative: Pt reported that she developed dark urine 2 days post vaccine. Pt states that the same thing happened when she received second dose of CV-19 vaccine.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Heart rate increased
Clinical narrative: Immediately after receiving the second Pfizer vaccine, she had a "rapid, heavy heart rate". It resolved but afterwards, she complained of dyspnea on exertion for 1.5 months (running on treadmill and walking to dorm on campus).
Age: 75.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Bronchitis, COVID-19, Chills, Cough, Productive cough
Clinical narrative: On 1/12/2022 I started feeling like I had bronchitis, I had some chills, fever, and wet coughing. I was coughing up phlegm. I did a teleconference with a doctor and she prescribed antibiotics and cough medicine and asked me to do a Covid-19 test. I did the Covid-19 test on 1/13 but the sample size was not sufficient. I had to retest on 1/18 and it came back positive. I did 2 tests on 1/24, negative antigen immediate test and the PCR came back positive. When I had the second test I did not have any symptoms except the cough. I still have the cough and I am still coughing up phlegm.
Age: 75.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Pyrexia, SARS-CoV-2 test negative, SARS-CoV-2 test positive
Clinical narrative: On 1/12/2022 I started feeling like I had bronchitis, I had some chills, fever, and wet coughing. I was coughing up phlegm. I did a teleconference with a doctor and she prescribed antibiotics and cough medicine and asked me to do a Covid-19 test. I did the Covid-19 test on 1/13 but the sample size was not sufficient. I had to retest on 1/18 and it came back positive. I did 2 tests on 1/24, negative antigen immediate test and the PCR came back positive. When I had the second test I did not have any symptoms except the cough. I still have the cough and I am still coughing up phlegm.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Member received 0.25 ml Moderna vaccine IM: according to CDC guidelines should have received 0.5 ml Moderna vaccine
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fall, Headache, Pyrexia
Clinical narrative: When I sat up to get up from bed, I felt extremely dizzy. I sat back down for a few moments and then got up again. I went into the kitchen and opened the refrigerator, but I fell on the floor. When I got up, I still felt really dizzy. I also had chills and a fever. I've been experiencing lightheadedness as well since taking that 3rd dose. I've been dealing with scalp issues and a strange headache too.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Skin disorder
Clinical narrative: When I sat up to get up from bed, I felt extremely dizzy. I sat back down for a few moments and then got up again. I went into the kitchen and opened the refrigerator, but I fell on the floor. When I got up, I still felt really dizzy. I also had chills and a fever. I've been experiencing lightheadedness as well since taking that 3rd dose. I've been dealing with scalp issues and a strange headache too.
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Rash pruritic
Clinical narrative: Patient had rash since Jan1,2022 all over body.  Itchy and worse at night.  Patient received the vaccine at the pharmacy.  Was seen in Urgent Care  1-4-22, then followed up with our office on 1-11-22.  Was given prednisolone at both places
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Cholangitis, Computerised tomogram abdomen abnormal, Diagnostic procedure, Flank pain, Inflammation
Clinical narrative: I began having pain on my right side in September. I went to the doctor and received an ultrasound and found out there was some inflammation of my right side. I then got a CT of my right side and more inflammation was found. In mid-Jan 2022 they did a procedure found out that my biliary duct was inflamed.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound abdomen abnormal
Clinical narrative: I began having pain on my right side in September. I went to the doctor and received an ultrasound and found out there was some inflammation of my right side. I then got a CT of my right side and more inflammation was found. In mid-Jan 2022 they did a procedure found out that my biliary duct was inflamed.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Heavy menstrual bleeding, Migraine, Syncope
Clinical narrative: Experienced massive blood clotting during following menstrual cycles, accompanied by migraine headache, shortness of breath, and fainting. These symptoms return each menstrual cycle since the second vaccine of the Moderna COVID-19 shot.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Product integrity issues, No adverse event reported, Patient received product that was expired by 1 day.
Age: 11.0
Sex: F
Vaccine: HPV9, MNQ, TDAP
Symptoms: Burning sensation, Skin exfoliation
Clinical narrative: patient developed burning inside arm after injection and subsequently developed a burn to the area of the left deltoid with subsequent desquamation of skin.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: General symptom
Clinical narrative: Onset of symptoms 1/18/22
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac monitoring normal, Condition aggravated, Dizziness, Nausea, Palpitations
Clinical narrative: Within hours of receiving the vaccine, my tinnitus, which began after the first dose of Moderna vaccine, increased to a 2-3 out of 10 and has continued to now. On 8/4/21, I developed severe, prolonged palpitations occurring several times a day until 8/17/21. During one episode, I felt dizzy, lightheaded, and slightly nauseous. A few more episodes occurred sporadically until 10/4/21. I have had no palpitations since then. I also developed palpitations 3.5 months after the first vaccine dose, but I was told they were not due to the vaccine. I went to see a cardiologist after the second set of palpitations on 8/18/21. He did not think they were due to the vaccine. He said that only young males get myocarditis from the COVID vaccine. I've never had palpitations like this before getting the Moderna vaccine and am afraid to get the booster shot. These incidents seem like too much to be a coincidence.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Within hours of receiving the vaccine, my tinnitus, which began after the first dose of Moderna vaccine, increased to a 2-3 out of 10 and has continued to now. On 8/4/21, I developed severe, prolonged palpitations occurring several times a day until 8/17/21. During one episode, I felt dizzy, lightheaded, and slightly nauseous. A few more episodes occurred sporadically until 10/4/21. I have had no palpitations since then. I also developed palpitations 3.5 months after the first vaccine dose, but I was told they were not due to the vaccine. I went to see a cardiologist after the second set of palpitations on 8/18/21. He did not think they were due to the vaccine. He said that only young males get myocarditis from the COVID vaccine. I've never had palpitations like this before getting the Moderna vaccine and am afraid to get the booster shot. These incidents seem like too much to be a coincidence.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Within 24 hours I broke out in Shingles.  Symptoms lasted for 2 weeks.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Angioedema, Aphonia, Blood test, Chest X-ray, Cough
Clinical narrative: Developed a sore throat a few hours receiving vaccine on 12-13-21.  Still have sore throat to this day.  In the meantime, I also developed cough (with green mucus), congestion, and overall sickness.  Still battling those symptoms.  On 12-22-21, developed hives.  Over the day and next few days, the hives spread to all over my body.  Still battling hives, itching, and angioedema to this day.  Went to ER on 12/22, 12/24, and 12/25, and then admitted into the hospital as an in-patient on 12/25.  Lips swelled, lost voice, throat felt like it was closing up.  Released on 12/27.  I am still sick with sore throat, cough, congestion, hives, itching, angioedema. Never before had hives in my life.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Lip swelling, Malaise, Oropharyngeal pain, Pruritus
Clinical narrative: Developed a sore throat a few hours receiving vaccine on 12-13-21.  Still have sore throat to this day.  In the meantime, I also developed cough (with green mucus), congestion, and overall sickness.  Still battling those symptoms.  On 12-22-21, developed hives.  Over the day and next few days, the hives spread to all over my body.  Still battling hives, itching, and angioedema to this day.  Went to ER on 12/22, 12/24, and 12/25, and then admitted into the hospital as an in-patient on 12/25.  Lips swelled, lost voice, throat felt like it was closing up.  Released on 12/27.  I am still sick with sore throat, cough, congestion, hives, itching, angioedema. Never before had hives in my life.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Respiratory tract congestion, SARS-CoV-2 test negative, Secretion discharge, Sputum discoloured
Clinical narrative: Developed a sore throat a few hours receiving vaccine on 12-13-21.  Still have sore throat to this day.  In the meantime, I also developed cough (with green mucus), congestion, and overall sickness.  Still battling those symptoms.  On 12-22-21, developed hives.  Over the day and next few days, the hives spread to all over my body.  Still battling hives, itching, and angioedema to this day.  Went to ER on 12/22, 12/24, and 12/25, and then admitted into the hospital as an in-patient on 12/25.  Lips swelled, lost voice, throat felt like it was closing up.  Released on 12/27.  I am still sick with sore throat, cough, congestion, hives, itching, angioedema. Never before had hives in my life.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Streptococcus test negative, Throat tightness, Urticaria
Clinical narrative: Developed a sore throat a few hours receiving vaccine on 12-13-21.  Still have sore throat to this day.  In the meantime, I also developed cough (with green mucus), congestion, and overall sickness.  Still battling those symptoms.  On 12-22-21, developed hives.  Over the day and next few days, the hives spread to all over my body.  Still battling hives, itching, and angioedema to this day.  Went to ER on 12/22, 12/24, and 12/25, and then admitted into the hospital as an in-patient on 12/25.  Lips swelled, lost voice, throat felt like it was closing up.  Released on 12/27.  I am still sick with sore throat, cough, congestion, hives, itching, angioedema. Never before had hives in my life.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abscess, Abscess drainage, COVID-19, Cellulitis, Chills
Clinical narrative: She completed the second Moderna Covid vaccine in May 2021. (Second Moderna vaccine: unable to read LOT number on her card, but received in the store). She started having buttock cellulitis 2 weeks prior to the hospital admission. She also experienced fever and chills. She came to ED at due to increased drainage of buttock abscess on 1/21/22 and was subsequently hospitalized on the same day. On 1/22/22, she was tested COVID positive as part of presurgical tests. She has not presented respiratory or GI symptoms. Hospital day 7, she is hemodynamically stable. She is still hospitalized since she may need another surgery for a buttock abscess.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Surgery
Clinical narrative: She completed the second Moderna Covid vaccine in May 2021. (Second Moderna vaccine: unable to read LOT number on her card, but received in the store). She started having buttock cellulitis 2 weeks prior to the hospital admission. She also experienced fever and chills. She came to ED at due to increased drainage of buttock abscess on 1/21/22 and was subsequently hospitalized on the same day. On 1/22/22, she was tested COVID positive as part of presurgical tests. She has not presented respiratory or GI symptoms. Hospital day 7, she is hemodynamically stable. She is still hospitalized since she may need another surgery for a buttock abscess.
Age: 96.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: This is an instance of breakthrough COVID-19 disease after which death occurred.  The individual was vaccinated with the Moderna product on 02/02/2021 and 03/02/2021. It is not known if they experienced COVID-19 specific symptoms, but tested positive for COVID-19 via PCR on 11/29/2021 at the skilled nursing facility at which they were a resident.  They then presented to emergency department on 12/11/2021 (the day after being released from isolation). They remained hospitalized until their death on 12/12/2021.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Bell's palsy, Facial paralysis, Nausea, Pain, Pyrexia
Clinical narrative: Fever pain for  2 days and some nausea then two weeks paralysis of right face developed Bell?s Palsy
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Asthenia, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal
Clinical narrative: COVID Breakthrough  Pfizer Dose 1 2/24/21 EN6198 Pfizer Dose 2 3/17/21 Lot:unknown  CV+ 9/4/21  9/21/21 The patient presents with difficulty breathing and Patient is a 77-year-old female who was seen and diagnosed with COVID on 9/4.  Chest x-ray was unremarkable at that time, patient discharged home with prescription for Levaquin secondary to UTI, presenting today with progressive shortness of breath.  Patient was hypoxic on arrival here today.  She complains of shortness of breath, cough, fever, weakness, fatigue.  Patient denies any abdominal pain, no dysuria.  Patient does states she felt like she was better until last night to this morning she experienced this worsening..  The onset was 1  days ago. The course/duration of symptoms is constant and worsening. Degree at onset mild.  Degree at present moderate.  The Exacerbating factors is none.  The Relieving factors is none.  Risk factors consist of COVID.  Prior episodes: none.  Therapy today: none.  Associated symptoms: fever and chills.  Patient is a 77-year-old female who was diagnosed with COVID on 09/04 is presenting today with worsening shortness of breath.  It is unclear, but does seem that patient did have some improvement, and now interval worsening.  Her prior x-ray on 09/04 was no acute disease.  Today the patient is hypoxic to 85%, requiring around 5 L of oxygen. She is tachycardic, febrile with bilateral crackles.  X-ray with interstitial changes, which actually was read as potential edema.  I actually suspect this infectious event probably a viral pneumonia from COVID.  There may be a secondary bacterial infection, therefore Levaquin was ordered.  Patient developed a rash following, this was listed as an allergy.  She had received no other medications besides this at this time.  She was treated with Benadryl and Pepcid.  Discussed patient with hospitalist, who did accept admission, requested I also add vancomycin and Decadron.  Will scan the patient for PE, but she does have CKD and therefore cannot tolerate a contrast scan.  We will order V/Q scan.  Patient is stable on oxygen as above.  V/Q scan resulted with high probability for PE.  Patient to be started on heparin. Hospitalist updated, added on BNP and troponin for signs of secondary heart strain.  Patient updated on findings.  Considered to be stable for floor..
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Dyspnoea, Fatigue, Hypoxia
Clinical narrative: COVID Breakthrough  Pfizer Dose 1 2/24/21 EN6198 Pfizer Dose 2 3/17/21 Lot:unknown  CV+ 9/4/21  9/21/21 The patient presents with difficulty breathing and Patient is a 77-year-old female who was seen and diagnosed with COVID on 9/4.  Chest x-ray was unremarkable at that time, patient discharged home with prescription for Levaquin secondary to UTI, presenting today with progressive shortness of breath.  Patient was hypoxic on arrival here today.  She complains of shortness of breath, cough, fever, weakness, fatigue.  Patient denies any abdominal pain, no dysuria.  Patient does states she felt like she was better until last night to this morning she experienced this worsening..  The onset was 1  days ago. The course/duration of symptoms is constant and worsening. Degree at onset mild.  Degree at present moderate.  The Exacerbating factors is none.  The Relieving factors is none.  Risk factors consist of COVID.  Prior episodes: none.  Therapy today: none.  Associated symptoms: fever and chills.  Patient is a 77-year-old female who was diagnosed with COVID on 09/04 is presenting today with worsening shortness of breath.  It is unclear, but does seem that patient did have some improvement, and now interval worsening.  Her prior x-ray on 09/04 was no acute disease.  Today the patient is hypoxic to 85%, requiring around 5 L of oxygen. She is tachycardic, febrile with bilateral crackles.  X-ray with interstitial changes, which actually was read as potential edema.  I actually suspect this infectious event probably a viral pneumonia from COVID.  There may be a secondary bacterial infection, therefore Levaquin was ordered.  Patient developed a rash following, this was listed as an allergy.  She had received no other medications besides this at this time.  She was treated with Benadryl and Pepcid.  Discussed patient with hospitalist, who did accept admission, requested I also add vancomycin and Decadron.  Will scan the patient for PE, but she does have CKD and therefore cannot tolerate a contrast scan.  We will order V/Q scan.  Patient is stable on oxygen as above.  V/Q scan resulted with high probability for PE.  Patient to be started on heparin. Hospitalist updated, added on BNP and troponin for signs of secondary heart strain.  Patient updated on findings.  Considered to be stable for floor..
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rales, SARS-CoV-2 test positive, Tachycardia, Urinary tract infection
Clinical narrative: COVID Breakthrough  Pfizer Dose 1 2/24/21 EN6198 Pfizer Dose 2 3/17/21 Lot:unknown  CV+ 9/4/21  9/21/21 The patient presents with difficulty breathing and Patient is a 77-year-old female who was seen and diagnosed with COVID on 9/4.  Chest x-ray was unremarkable at that time, patient discharged home with prescription for Levaquin secondary to UTI, presenting today with progressive shortness of breath.  Patient was hypoxic on arrival here today.  She complains of shortness of breath, cough, fever, weakness, fatigue.  Patient denies any abdominal pain, no dysuria.  Patient does states she felt like she was better until last night to this morning she experienced this worsening..  The onset was 1  days ago. The course/duration of symptoms is constant and worsening. Degree at onset mild.  Degree at present moderate.  The Exacerbating factors is none.  The Relieving factors is none.  Risk factors consist of COVID.  Prior episodes: none.  Therapy today: none.  Associated symptoms: fever and chills.  Patient is a 77-year-old female who was diagnosed with COVID on 09/04 is presenting today with worsening shortness of breath.  It is unclear, but does seem that patient did have some improvement, and now interval worsening.  Her prior x-ray on 09/04 was no acute disease.  Today the patient is hypoxic to 85%, requiring around 5 L of oxygen. She is tachycardic, febrile with bilateral crackles.  X-ray with interstitial changes, which actually was read as potential edema.  I actually suspect this infectious event probably a viral pneumonia from COVID.  There may be a secondary bacterial infection, therefore Levaquin was ordered.  Patient developed a rash following, this was listed as an allergy.  She had received no other medications besides this at this time.  She was treated with Benadryl and Pepcid.  Discussed patient with hospitalist, who did accept admission, requested I also add vancomycin and Decadron.  Will scan the patient for PE, but she does have CKD and therefore cannot tolerate a contrast scan.  We will order V/Q scan.  Patient is stable on oxygen as above.  V/Q scan resulted with high probability for PE.  Patient to be started on heparin. Hospitalist updated, added on BNP and troponin for signs of secondary heart strain.  Patient updated on findings.  Considered to be stable for floor..
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccine breakthrough infection, Ventilation/perfusion scan abnormal
Clinical narrative: COVID Breakthrough  Pfizer Dose 1 2/24/21 EN6198 Pfizer Dose 2 3/17/21 Lot:unknown  CV+ 9/4/21  9/21/21 The patient presents with difficulty breathing and Patient is a 77-year-old female who was seen and diagnosed with COVID on 9/4.  Chest x-ray was unremarkable at that time, patient discharged home with prescription for Levaquin secondary to UTI, presenting today with progressive shortness of breath.  Patient was hypoxic on arrival here today.  She complains of shortness of breath, cough, fever, weakness, fatigue.  Patient denies any abdominal pain, no dysuria.  Patient does states she felt like she was better until last night to this morning she experienced this worsening..  The onset was 1  days ago. The course/duration of symptoms is constant and worsening. Degree at onset mild.  Degree at present moderate.  The Exacerbating factors is none.  The Relieving factors is none.  Risk factors consist of COVID.  Prior episodes: none.  Therapy today: none.  Associated symptoms: fever and chills.  Patient is a 77-year-old female who was diagnosed with COVID on 09/04 is presenting today with worsening shortness of breath.  It is unclear, but does seem that patient did have some improvement, and now interval worsening.  Her prior x-ray on 09/04 was no acute disease.  Today the patient is hypoxic to 85%, requiring around 5 L of oxygen. She is tachycardic, febrile with bilateral crackles.  X-ray with interstitial changes, which actually was read as potential edema.  I actually suspect this infectious event probably a viral pneumonia from COVID.  There may be a secondary bacterial infection, therefore Levaquin was ordered.  Patient developed a rash following, this was listed as an allergy.  She had received no other medications besides this at this time.  She was treated with Benadryl and Pepcid.  Discussed patient with hospitalist, who did accept admission, requested I also add vancomycin and Decadron.  Will scan the patient for PE, but she does have CKD and therefore cannot tolerate a contrast scan.  We will order V/Q scan.  Patient is stable on oxygen as above.  V/Q scan resulted with high probability for PE.  Patient to be started on heparin. Hospitalist updated, added on BNP and troponin for signs of secondary heart strain.  Patient updated on findings.  Considered to be stable for floor..
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Headache, Oropharyngeal pain
Clinical narrative: On the 13th I started to have what I thought was a sore throat, coughing, headache and fatigue and congestion. They got worse for a couple days for a week, about until the 20th. The cough has continued. I did an in home test for strep throat and it was negative. I called and had a virtual visit with UC and they told me to go get tested. I went to a drive through testing site and that night or next morning I got my results and it was positive. I took over the counter cold and flu medication and Tylenol as needed.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive, Streptococcus test negative
Clinical narrative: On the 13th I started to have what I thought was a sore throat, coughing, headache and fatigue and congestion. They got worse for a couple days for a week, about until the 20th. The cough has continued. I did an in home test for strep throat and it was negative. I called and had a virtual visit with UC and they told me to go get tested. I went to a drive through testing site and that night or next morning I got my results and it was positive. I took over the counter cold and flu medication and Tylenol as needed.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Haemorrhoids
Clinical narrative: Suffered from hemorrhoids for two weeks. Never before had suffered from the condition. Chills and dizziness for three days.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood test, Chest X-ray, Computerised tomogram thorax, Deep vein thrombosis
Clinical narrative: AE started on Jan/3/2022 as a cramp in calf of righ leg which resolved in a day without treatment. Cramp re-started in calf of the same leg on Jan/12/2022, and extended to upper leg muscles on Jan/13/2022 which did not resolve. In the morning of Jan/15/2022 I felt short of breath and weakness after minor physical activity and went to seek emergency care and was immediately hospitalized with bilaterlal pulmonary embolism and deep vein thrombosis in right leg.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Echocardiogram, Electrocardiogram, Muscle spasms, Pulmonary embolism
Clinical narrative: AE started on Jan/3/2022 as a cramp in calf of righ leg which resolved in a day without treatment. Cramp re-started in calf of the same leg on Jan/12/2022, and extended to upper leg muscles on Jan/13/2022 which did not resolve. In the morning of Jan/15/2022 I felt short of breath and weakness after minor physical activity and went to seek emergency care and was immediately hospitalized with bilaterlal pulmonary embolism and deep vein thrombosis in right leg.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Ultrasound scan
Clinical narrative: AE started on Jan/3/2022 as a cramp in calf of righ leg which resolved in a day without treatment. Cramp re-started in calf of the same leg on Jan/12/2022, and extended to upper leg muscles on Jan/13/2022 which did not resolve. In the morning of Jan/15/2022 I felt short of breath and weakness after minor physical activity and went to seek emergency care and was immediately hospitalized with bilaterlal pulmonary embolism and deep vein thrombosis in right leg.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Patient received 0.25 ml Moderna vaccine IM: according to CDC guidelines should have received 0.5 ml Moderna vaccine
Age: 52.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache
Clinical narrative: Pt. states that after the 1st dose of Shingrix 01/26/2022, started experiencing symptoms that evening of a severe headache on the Left side of the head continuing. No noted Primary visit/communications.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Dyspnoea, Dyspnoea exertional
Clinical narrative: COVID Breakthrough Case  Moderna Dose 1 4/8/21 (030B21A) Moderna Dose 2 5/6/21 (017C21A) COVID Positive 9/16/21  9/16/21: patient speaks limited language.  History is obtained with assistance of on-line interpretation services.  He presented to emergency department with worsening shortness of breath of 5 days duration. Gradually getting worse.  He came to hospital because he could not catch  breath.  Activity makes him more short of breath. His wife and daughter tested positive for SARS-CoV-2 last Monday.  He was found to be hypoxic with pulse ox of 56% on room air.  He also tested positive for SARS-CoV-2.  Chest x-ray showed bilateral lung infiltrates suggestive of viral pneumonitis.  He denied fever.  Denied nausea, vomiting or diarrhea.  Denied hemoptysis denied chest pain.  9/25/21: Patient was admitted on September 16, 2021 for evaluation of COVID pneumonia.  Patient was requiring high oxygen demand when he reached the ICU.  Pulmonology was consulted and he placed the patient on OptiFlow for a significant portion of his hospitalization.  For the patient's COVID management he received 5 days of remdesivir, 10 days of Decadron, 3 days of Levaquin.  The patient's hospitalization was complicated by persistent high oxygen demand.  A walk test for determination of home oxygen was performed prior to discharge and resulted in the patient requiring 2 L at all times.  Patient was unable to obtain home health due to his insurance status.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Intensive care, Lung infiltration, Pneumonia viral, SARS-CoV-2 test positive
Clinical narrative: COVID Breakthrough Case  Moderna Dose 1 4/8/21 (030B21A) Moderna Dose 2 5/6/21 (017C21A) COVID Positive 9/16/21  9/16/21: patient speaks limited language.  History is obtained with assistance of on-line interpretation services.  He presented to emergency department with worsening shortness of breath of 5 days duration. Gradually getting worse.  He came to hospital because he could not catch  breath.  Activity makes him more short of breath. His wife and daughter tested positive for SARS-CoV-2 last Monday.  He was found to be hypoxic with pulse ox of 56% on room air.  He also tested positive for SARS-CoV-2.  Chest x-ray showed bilateral lung infiltrates suggestive of viral pneumonitis.  He denied fever.  Denied nausea, vomiting or diarrhea.  Denied hemoptysis denied chest pain.  9/25/21: Patient was admitted on September 16, 2021 for evaluation of COVID pneumonia.  Patient was requiring high oxygen demand when he reached the ICU.  Pulmonology was consulted and he placed the patient on OptiFlow for a significant portion of his hospitalization.  For the patient's COVID management he received 5 days of remdesivir, 10 days of Decadron, 3 days of Levaquin.  The patient's hospitalization was complicated by persistent high oxygen demand.  A walk test for determination of home oxygen was performed prior to discharge and resulted in the patient requiring 2 L at all times.  Patient was unable to obtain home health due to his insurance status.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccine breakthrough infection, Walking distance test abnormal
Clinical narrative: COVID Breakthrough Case  Moderna Dose 1 4/8/21 (030B21A) Moderna Dose 2 5/6/21 (017C21A) COVID Positive 9/16/21  9/16/21: patient speaks limited language.  History is obtained with assistance of on-line interpretation services.  He presented to emergency department with worsening shortness of breath of 5 days duration. Gradually getting worse.  He came to hospital because he could not catch  breath.  Activity makes him more short of breath. His wife and daughter tested positive for SARS-CoV-2 last Monday.  He was found to be hypoxic with pulse ox of 56% on room air.  He also tested positive for SARS-CoV-2.  Chest x-ray showed bilateral lung infiltrates suggestive of viral pneumonitis.  He denied fever.  Denied nausea, vomiting or diarrhea.  Denied hemoptysis denied chest pain.  9/25/21: Patient was admitted on September 16, 2021 for evaluation of COVID pneumonia.  Patient was requiring high oxygen demand when he reached the ICU.  Pulmonology was consulted and he placed the patient on OptiFlow for a significant portion of his hospitalization.  For the patient's COVID management he received 5 days of remdesivir, 10 days of Decadron, 3 days of Levaquin.  The patient's hospitalization was complicated by persistent high oxygen demand.  A walk test for determination of home oxygen was performed prior to discharge and resulted in the patient requiring 2 L at all times.  Patient was unable to obtain home health due to his insurance status.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Lymphadenopathy
Clinical narrative: Rash appeared below injection site less than a day after booster shot. Same rash appeared 7 days after initial Moderna vaccination on 05/20/21. Swollen lymph nodes under arms with all three vaccinations, but no rash on the second vaccination. Rash stayed for 5-6 days initially. Benadryl helped.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Pt received Moderna vaccination at 17 years old.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Eye swelling, Fatigue, Gastrooesophageal reflux disease, Head discomfort
Clinical narrative: Numbness in legs, sensitivity in the head area, fatigue, swollen and red eyes. Severe hives covering entire body including scalp of the head, difficulty breathing, sore throat, reflux worsened. Was prescribed Prednisone by healthcare professional.  Rash/hives come and go.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Ocular hyperaemia, Oropharyngeal pain, Urticaria
Clinical narrative: Numbness in legs, sensitivity in the head area, fatigue, swollen and red eyes. Severe hives covering entire body including scalp of the head, difficulty breathing, sore throat, reflux worsened. Was prescribed Prednisone by healthcare professional.  Rash/hives come and go.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Patient came down to employee health to get moderna booster shot. She explained to LPN that she finished her 2 dose series 7 months ago. Patient received 0.25ml of moderna in left deltoid. While writer was inputting information into database writer had realized patients last pfizer vaccine was 09/21/22 making her not eligible for the booster until 02/21/2022. Patient was made aware that she received the booster prior to her scheduled time. At this time patient has no side effects or issues and feels fine. Vaers completed over phone with patient.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: Good
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Oropharyngeal pain, Pyrexia
Clinical narrative: 1/1/2022 Sore throat, cough, short of breath, fever of 101.7° On 01/04 called my doctor and he called in a prednisone pack. And as a (Privacy), I knew I had to Tylenol and Motrin, Cold medicines (Mucinex day and night), Zinc. I got a Covid PCR on 01/05 and it came back positive on the 01/06. Recovery from this took until 1/10 and I am fully recovered.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: 1/1/2022 Sore throat, cough, short of breath, fever of 101.7° On 01/04 called my doctor and he called in a prednisone pack. And as a (Privacy), I knew I had to Tylenol and Motrin, Cold medicines (Mucinex day and night), Zinc. I got a Covid PCR on 01/05 and it came back positive on the 01/06. Recovery from this took until 1/10 and I am fully recovered.
Age: 91.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Fully vaccinated, not boosted.  COVID infection breakthrough
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Unknown
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose increased, Blood pH decreased, COVID-19, COVID-19 pneumonia, Carbon dioxide decreased
Clinical narrative: COVID Breakthrough Case Pfizer Dose 1 3/13/21 (EN6204) Pfizer Dose 2 4/3/21 (ER8729) COVID Positive 9/17/21  9/16/21: patient is a 54 year old female who presented to ED with complaints of shortness of breath. Patient has a past medical history of multiple sclerosis, hyperlipidemia, hypothyroidism, uncontrolled type 2 diabetes mellitus and anxiety/depression. She began feeling ill two weeks ago. She developed nasal congestion, right ear pain and diarrhea. She was seen at urgent care on Sept 12th and started on Augmentin. Her symptoms have progressively worsened. She has become severely short of breath, especially with exertion. No chest pain. Decreased appetite and oral intake. Reports ongoing nausea and vomiting, with persistent diarrhea. She developed a fever yesterday and dry cough. She went back to urgent care today and her pulse ox was in the 80s, she was referred to ED for further evaluation and treatment. She has been fully Covid-19 vaccinated.  On arrival to ED patient was febrile 101.6, tachycardic 117 and hypoxic on room air at 86%. 5 L nasal cannula was applied with improvement oxygenation saturation to 94%. Laboratory findings were significant for CO2 14, pH 7.31, pCO2 37 hyperglycemia 339. ProBNP 359.Rapid COVID positive. IV Levaquin initiated in ED.  IV fluid resuscitation given with LR 5 L bolus.  Decadron and DuoNebs initiated in ED. chest x-ray showed bilateral pneumonia.  10/1/21: 54-year-old lady presented to the emergency room with worsening shortness of breath.  The patient was noted to be hypoxic and admitted for COVID-19 pneumonia.  She was intubated 3 days later and put on the vent for severe hypoxic respiratory failure.  The patient received standard treatment for COVID-19 infection that improved on remdesivir, dexamethasone, empiric antibiotic therapy.  The patient received a standard treatment for COVID-19 infection.  She was eventually extubated.  She is doing much better.  She is only on 2 L of oxygen via nasal cannula at rest and with activity.  The patient is recuperating well with physical therapy.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Cough, Decreased appetite, Diarrhoea, Dyspnoea
Clinical narrative: COVID Breakthrough Case Pfizer Dose 1 3/13/21 (EN6204) Pfizer Dose 2 4/3/21 (ER8729) COVID Positive 9/17/21  9/16/21: patient is a 54 year old female who presented to ED with complaints of shortness of breath. Patient has a past medical history of multiple sclerosis, hyperlipidemia, hypothyroidism, uncontrolled type 2 diabetes mellitus and anxiety/depression. She began feeling ill two weeks ago. She developed nasal congestion, right ear pain and diarrhea. She was seen at urgent care on Sept 12th and started on Augmentin. Her symptoms have progressively worsened. She has become severely short of breath, especially with exertion. No chest pain. Decreased appetite and oral intake. Reports ongoing nausea and vomiting, with persistent diarrhea. She developed a fever yesterday and dry cough. She went back to urgent care today and her pulse ox was in the 80s, she was referred to ED for further evaluation and treatment. She has been fully Covid-19 vaccinated.  On arrival to ED patient was febrile 101.6, tachycardic 117 and hypoxic on room air at 86%. 5 L nasal cannula was applied with improvement oxygenation saturation to 94%. Laboratory findings were significant for CO2 14, pH 7.31, pCO2 37 hyperglycemia 339. ProBNP 359.Rapid COVID positive. IV Levaquin initiated in ED.  IV fluid resuscitation given with LR 5 L bolus.  Decadron and DuoNebs initiated in ED. chest x-ray showed bilateral pneumonia.  10/1/21: 54-year-old lady presented to the emergency room with worsening shortness of breath.  The patient was noted to be hypoxic and admitted for COVID-19 pneumonia.  She was intubated 3 days later and put on the vent for severe hypoxic respiratory failure.  The patient received standard treatment for COVID-19 infection that improved on remdesivir, dexamethasone, empiric antibiotic therapy.  The patient received a standard treatment for COVID-19 infection.  She was eventually extubated.  She is doing much better.  She is only on 2 L of oxygen via nasal cannula at rest and with activity.  The patient is recuperating well with physical therapy.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea exertional, Ear pain, Endotracheal intubation, Hyperglycaemia, Hypophagia
Clinical narrative: COVID Breakthrough Case Pfizer Dose 1 3/13/21 (EN6204) Pfizer Dose 2 4/3/21 (ER8729) COVID Positive 9/17/21  9/16/21: patient is a 54 year old female who presented to ED with complaints of shortness of breath. Patient has a past medical history of multiple sclerosis, hyperlipidemia, hypothyroidism, uncontrolled type 2 diabetes mellitus and anxiety/depression. She began feeling ill two weeks ago. She developed nasal congestion, right ear pain and diarrhea. She was seen at urgent care on Sept 12th and started on Augmentin. Her symptoms have progressively worsened. She has become severely short of breath, especially with exertion. No chest pain. Decreased appetite and oral intake. Reports ongoing nausea and vomiting, with persistent diarrhea. She developed a fever yesterday and dry cough. She went back to urgent care today and her pulse ox was in the 80s, she was referred to ED for further evaluation and treatment. She has been fully Covid-19 vaccinated.  On arrival to ED patient was febrile 101.6, tachycardic 117 and hypoxic on room air at 86%. 5 L nasal cannula was applied with improvement oxygenation saturation to 94%. Laboratory findings were significant for CO2 14, pH 7.31, pCO2 37 hyperglycemia 339. ProBNP 359.Rapid COVID positive. IV Levaquin initiated in ED.  IV fluid resuscitation given with LR 5 L bolus.  Decadron and DuoNebs initiated in ED. chest x-ray showed bilateral pneumonia.  10/1/21: 54-year-old lady presented to the emergency room with worsening shortness of breath.  The patient was noted to be hypoxic and admitted for COVID-19 pneumonia.  She was intubated 3 days later and put on the vent for severe hypoxic respiratory failure.  The patient received standard treatment for COVID-19 infection that improved on remdesivir, dexamethasone, empiric antibiotic therapy.  The patient received a standard treatment for COVID-19 infection.  She was eventually extubated.  She is doing much better.  She is only on 2 L of oxygen via nasal cannula at rest and with activity.  The patient is recuperating well with physical therapy.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Laboratory test, Malaise, Mechanical ventilation, Nasal congestion
Clinical narrative: COVID Breakthrough Case Pfizer Dose 1 3/13/21 (EN6204) Pfizer Dose 2 4/3/21 (ER8729) COVID Positive 9/17/21  9/16/21: patient is a 54 year old female who presented to ED with complaints of shortness of breath. Patient has a past medical history of multiple sclerosis, hyperlipidemia, hypothyroidism, uncontrolled type 2 diabetes mellitus and anxiety/depression. She began feeling ill two weeks ago. She developed nasal congestion, right ear pain and diarrhea. She was seen at urgent care on Sept 12th and started on Augmentin. Her symptoms have progressively worsened. She has become severely short of breath, especially with exertion. No chest pain. Decreased appetite and oral intake. Reports ongoing nausea and vomiting, with persistent diarrhea. She developed a fever yesterday and dry cough. She went back to urgent care today and her pulse ox was in the 80s, she was referred to ED for further evaluation and treatment. She has been fully Covid-19 vaccinated.  On arrival to ED patient was febrile 101.6, tachycardic 117 and hypoxic on room air at 86%. 5 L nasal cannula was applied with improvement oxygenation saturation to 94%. Laboratory findings were significant for CO2 14, pH 7.31, pCO2 37 hyperglycemia 339. ProBNP 359.Rapid COVID positive. IV Levaquin initiated in ED.  IV fluid resuscitation given with LR 5 L bolus.  Decadron and DuoNebs initiated in ED. chest x-ray showed bilateral pneumonia.  10/1/21: 54-year-old lady presented to the emergency room with worsening shortness of breath.  The patient was noted to be hypoxic and admitted for COVID-19 pneumonia.  She was intubated 3 days later and put on the vent for severe hypoxic respiratory failure.  The patient received standard treatment for COVID-19 infection that improved on remdesivir, dexamethasone, empiric antibiotic therapy.  The patient received a standard treatment for COVID-19 infection.  She was eventually extubated.  She is doing much better.  She is only on 2 L of oxygen via nasal cannula at rest and with activity.  The patient is recuperating well with physical therapy.